Guangxi Liuzhou Pharm Co Ltd (603368) - Total Liabilities

Latest as of September 2025: CN¥13.05 Billion CNY ≈ $1.91 Billion USD

Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) has total liabilities worth CN¥13.05 Billion CNY (≈ $1.91 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Guangxi Liuzhou Pharm Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Guangxi Liuzhou Pharm Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

Guangxi Liuzhou Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guangxi Liuzhou Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
CH. Karnchang PCL BK:CK	Thailand	฿87.98 Billion
Zhejiang Int'L Group Co Ltd SHE:000411	China	CN¥11.95 Billion
Guangzhou Automobile Group Co. Ltd F:02G	Germany	€115.67 Billion
Shenzhen Shengxunda Technology Co Ltd Class A SHE:300518	China	CN¥116.97 Million
Evotec SE XETRA:EVT	Germany	€940.19 Million
Shentong Technology Group Co Ltd SHG:605228	China	CN¥754.83 Million
Hanwha Investment&Securities Co Ltd KO:003530	Korea	₩15.29 Trillion
Kyobo Securiti KO:030610	Korea	₩17.15 Trillion

Liability Composition Analysis (2011–2024)

This chart breaks down Guangxi Liuzhou Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603368 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.64	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.67	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.62	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangxi Liuzhou Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangxi Liuzhou Pharm Co Ltd (2011–2024)

The table below shows the annual total liabilities of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥13.33 Billion ≈ $1.95 Billion	+1.80%
2023-12-31	CN¥13.10 Billion ≈ $1.92 Billion	+6.98%
2022-12-31	CN¥12.24 Billion ≈ $1.79 Billion	+21.58%
2021-12-31	CN¥10.07 Billion ≈ $1.47 Billion	+7.53%
2020-12-31	CN¥9.36 Billion ≈ $1.37 Billion	+28.25%
2019-12-31	CN¥7.30 Billion ≈ $1.07 Billion	+27.51%
2018-12-31	CN¥5.73 Billion ≈ $837.83 Million	+43.66%
2017-12-31	CN¥3.99 Billion ≈ $583.21 Million	+31.05%
2016-12-31	CN¥3.04 Billion ≈ $445.02 Million	+3.29%
2015-12-31	CN¥2.94 Billion ≈ $430.85 Million	+14.94%
2014-12-31	CN¥2.56 Billion ≈ $374.86 Million	+16.61%
2013-12-31	CN¥2.20 Billion ≈ $321.47 Million	+33.08%
2012-12-31	CN¥1.65 Billion ≈ $241.56 Million	+27.04%
2011-12-31	CN¥1.30 Billion ≈ $190.15 Million	--

About Guangxi Liuzhou Pharm Co Ltd

SHG:603368 China Medical Distribution

Market Cap

$920.11 Million

CN¥6.29 Billion CNY

Market Cap Rank

#9523 Global

#2558 in China

Share Price

CN¥15.83

Change (1 day)

-1.25%

52-Week Range

CN¥15.83 - CN¥20.31

All Time High

CN¥62.90